Genomic sequencing of a pregnancy associated symptomatic meningioma of the diaphragma sellae: a case report

References

• Ostrom QT, Patil N, Cioffi G, et al. CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2013–2017. Neuro Oncol 2020;22:iv1–96.
   PubMed Web of Science ®Google Scholar
• Nanda A, Bir SC, Maiti TK, et al. Relevance of Simpson grading system and recurrence-free survival after surgery for World Health Organization Grade I meningioma. JNS 2017;126:201–11.
   PubMed Web of Science ®Google Scholar
• Simpson D. The recurrence of intracranial meningiomas after surgical treatment. J Neurol Neurosurg Psychiatry 1957;20:22–39.
   PubMed Web of Science ®Google Scholar
• Apra C, Peyre M, Kalamarides M. Current treatment options for meningioma. Expert Rev Neurother 2018;18:241–9.
   PubMed Web of Science ®Google Scholar
• Mallari RJ, Thakur JD, Griffiths C, et al. Tuberculum sellae meningiomas in pregnancy: 3 cases treated in the second trimester and literature review. World Neurosurg 2020;143:268–75.
   PubMed Web of Science ®Google Scholar
• Ananda G, Mockus S, Lundquist M, et al. Development and validation of the JAX Cancer Treatment Profile for detection of clinically actionable mutations in solid tumors. Exp Mol Pathol 2015;98:106–12.
   PubMed Web of Science ®Google Scholar
• Laviv Y, Bayoumi A, Mahadevan A, et al. Meningiomas in pregnancy: timing of surgery and clinical outcomes as observed in 104 cases and establishment of a best management strategy. Acta Neurochir 2018;160:1521–9.
   PubMed Web of Science ®Google Scholar
• Kong CC, et al. Incidence, clinico-radiological features and outcome of skull base versus non-skull base meningiomas treated in Kuala Lumpur general hospital: a five-year experience. Malays J Med Sci 2018;25:88–102.
   PubMed Web of Science ®Google Scholar
• Meling TR, Da Broi M, Scheie D, et al. Meningiomas: skull base versus non-skull base. Neurosurg Rev 2019;42:163–73.
   PubMed Web of Science ®Google Scholar
• Lusis EA, Scheithauer BW, Yachnis AT, et al. Meningiomas in pregnancy: a clinicopathologic study of 17 cases. Neurosurgery 2012;71:951–61.
   PubMed Web of Science ®Google Scholar
• Priddy BH, Otto BA, Carrau RL, et al. Management of skull base tumors in the obstetric population: a case series. World Neurosurg 2018;113:e373–82.
   PubMed Web of Science ®Google Scholar
• Wiemels J, Wrensch M, Claus EB. Epidemiology and etiology of meningioma. J Neurooncol 2010;99:307–14.
   PubMed Web of Science ®Google Scholar
• Casabella AM, et al. Management of foramen magnum meningioma during pregnancy: literature review and case report. World Neurosurg 2017;97:752 e715–752 e718.
   Web of Science ®Google Scholar
• Chakravarthy V, Kaplan B, Gospodarev V, et al. Houdini tumor: case report and literature review of pregnancy-associated meningioma. World Neurosurg 2018;114:e1261–5.
   PubMed Web of Science ®Google Scholar
• Kerschbaumer J, Freyschlag CF, Stockhammer G, et al. Hormone-dependent shrinkage of a sphenoid wing meningioma after pregnancy: case report. J Neurosurg 2016;124:137–40.
   PubMed Web of Science ®Google Scholar
• Phang SY, Whitfield P. Postpartum regression of a presumed cavernous meningioma. Case Rep Oncol Med 2016;2016:2649426.
   PubMedGoogle Scholar
• Custer B, Longstreth WT, Phillips LE, et al. Hormonal exposures and the risk of intracranial meningioma in women: a population-based case-control study. BMC Cancer 2006;6:152.
   PubMed Web of Science ®Google Scholar
• Korhonen K, Salminen T, Raitanen J, et al. Female predominance in meningiomas can not be explained by differences in progesterone, estrogen, or androgen receptor expression. J Neurooncol 2006;80:1–7.
   PubMed Web of Science ®Google Scholar
• Clark VE, Erson-Omay EZ, Serin A, et al. Genomic analysis of non-NF2 meningiomas reveals mutations in TRAF7, KLF4, AKT1, and SMO. Science 2013;339:1077–80.
   PubMed Web of Science ®Google Scholar
• Yuzawa S, Nishihara H, Tanaka S. Genetic landscape of meningioma. Brain Tumor Pathol 2016;33:237–47.
   PubMed Web of Science ®Google Scholar
• Karsy M, Azab MA, Abou-Al-Shaar H, et al. Clinical potential of meningioma genomic insights: a practical review for neurosurgeons. Neurosurg Focus 2018;44:E10.
   Web of Science ®Google Scholar
• Lee Y, Liu J, Patel S, et al. Genomic landscape of meningiomas. Brain Pathol 2010;20:751–62.
   PubMed Web of Science ®Google Scholar
• Suppiah S, Nassiri F, Bi WL, et al. Molecular and translational advances in meningiomas. Neuro Oncol 2019;21:i4–17.
   PubMed Web of Science ®Google Scholar
• Nassiri F, Mamatjan Y, Suppiah S, et al. DNA methylation profiling to predict recurrence risk in meningioma: development and validation of a nomogram to optimize clinical management. Neuro Oncol 2019;21:901–10.
   PubMed Web of Science ®Google Scholar
• Nassiri F, Liu J, Patil V, et al. A clinically applicable integrative molecular classification of meningiomas. Nature 2021;597:119–25.
   PubMed Web of Science ®Google Scholar
• Sahm F, Schrimpf D, Stichel D, et al. DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis. Lancet Oncol 2017;18:682–94.
   PubMed Web of Science ®Google Scholar
• Smith MJ. Germline and somatic mutations in meningiomas. Cancer Genet 2015;208:107–14.
   PubMed Web of Science ®Google Scholar
• Arnli MB, Winther TL, Lydersen S, et al. Prognostic value of ErbB2/HER2 in human meningiomas. PLoS One 2018;13:e0205846.
   PubMed Web of Science ®Google Scholar
• Ichimura S, Ohara K, Kono M, et al. Molecular investigation of brain tumors progressing during pregnancy or postpartum period: the association between tumor type, their receptors, and the timing of presentation. Clin Neurol Neurosurg 2021;207:106720.
   PubMed Web of Science ®Google Scholar
• Dunn IF, Du Z, Touat M, et al. Mismatch repair deficiency in high-grade meningioma: a rare but recurrent event associated with dramatic immune activation and clinical response to PD-1 blockade. JCO Precis Oncol 2018;2018:1–12.
   Google Scholar
• Pecina-Slaus N, et al. Genetic changes of MLH1 and MSH2 genes could explain constant findings on microsatellite instability in intracranial meningioma. Tumour Biol 2017;39:1010428317705791.
   Google Scholar
• Viale G, Trapani D, Curigliano G. Mismatch repair deficiency as a predictive biomarker for immunotherapy efficacy. Biomed Res Int 2017;2017:4719194.
   PubMed Web of Science ®Google Scholar
• Ji YI, Kim KT. Gynecologic malignancy in pregnancy. Obstet Gynecol Sci 2013;56:289–300.
   PubMedGoogle Scholar
• Azim HA, Brohee S, Peccatori FA, Jr., et al. Biology of breast cancer during pregnancy using genomic profiling. Endocr Relat Cancer 2014;21:545–54.
   PubMed Web of Science ®Google Scholar
• Korakiti A-M, Moutafi M, Zografos E, et al. The genomic profile of pregnancy-associated breast cancer: a systematic review. Front Oncol 2020;10:1773.
   PubMed Web of Science ®Google Scholar
• Zografos E, Korakiti A-M, Andrikopoulou A, et al. Germline mutations in a clinic-based series of pregnancy associated breast cancer patients. BMC Cancer 2021;21:572.
   PubMed Web of Science ®Google Scholar
• Raoul J-L, Heymann M-F, Dumont F, et al. Case report: grade 2 metastatic pancreatic neuroendocrine tumor with progression of one metastasis after pregnancy to grade 3 large-cell neuroendocrine carcinoma: one case cured by resection with genomic characterization of the two components. Front Oncol 2021;11:646992.
   PubMed Web of Science ®Google Scholar
• Jung S-H, Choi YJ, Kim MS, et al. Distinct genomic profiles of gestational choriocarcinoma, a unique cancer of pregnant tissues. Exp Mol Med 2020;52:2046–54.
   PubMed Web of Science ®Google Scholar